We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01371695
Recruitment Status : Unknown
Verified June 2011 by Onconix, Inc.
Recruitment status was:  Enrolling by invitation
First Posted : June 13, 2011
Last Update Posted : June 13, 2011
Information provided by:
Onconix, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2011
  Estimated Study Completion Date : September 2013